Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression
- PMID: 19016087
- DOI: 10.1080/00048670802512073
Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression
Abstract
Stress during childhood and adolescence has implications for the extent of depression and psychotic disorders in maturity. Stressful events lead to the regression of synapses with the loss of synaptic spines and in some cases whole dendrites of pyramidal neurons in the prefrontal cortex, a process that leads to the malfunctioning of neural networks in the neocortex. Such stress often shows concomitant increases in the activity of the hypothalamic-pituitary-adrenal system, with a consequent elevated release of glucocorticoids such as cortisol as well as of corticotropin-releasing hormone (CRH) from neurons. It is very likely that it is these hormones, acting on neuronal and astrocyte glucocorticoid receptors (GRs) and CRH receptors, respectively, that are responsible for the regression of synapses. The mechanism of such regression involves the loss of synaptic spines, the stability of which is under the direct control of the activity of N-methyl-d-aspartate (NMDA) receptors on the spines. Glutamate activates NMDA receptors, which then, through parallel pathways, control the extent in the spine of the cytoskeletal protein F-actin and so spine stability and growth. Both GR and CRH receptors in the spines can modulate NMDA receptors, reducing their activation by glutamate and hence spine stability. In contrast, glucocorticoids, probably acting on nerve terminal and astrocyte GRs, can release glutamate, so promoting NMDA receptor activation. It is suggested that spine stability is under dual control by glucocorticoids and CRH, released during stress to change the stability of synaptic spines, leading to the malfunctioning of cortical neural networks that are involved in depression and psychoses.
Similar articles
-
Stress responsive neurohormones in depression and anxiety.Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S207-14. doi: 10.1055/s-2003-45132. Pharmacopsychiatry. 2003. PMID: 14677081 Review.
-
[The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].Nervenarzt. 2003 Mar;74(3):279-91; quiz 292. doi: 10.1007/s00115-002-1444-7. Nervenarzt. 2003. PMID: 12627245 German.
-
Synaptic P2X7 receptor regenerative-loop hypothesis for depression.Aust N Z J Psychiatry. 2007 Jul;41(7):563-71. doi: 10.1080/00048670701399994. Aust N Z J Psychiatry. 2007. PMID: 17558618
-
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.Psychiatry Res. 2007 Aug 15;155(3):245-56. doi: 10.1016/j.pscychresns.2006.11.002. Epub 2007 Jun 22. Psychiatry Res. 2007. PMID: 17587554
-
Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.Dev Psychopathol. 2006 Summer;18(3):853-76. Dev Psychopathol. 2006. PMID: 17152404 Review.
Cited by
-
Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities.PLoS One. 2010 Oct 18;5(10):e13447. doi: 10.1371/journal.pone.0013447. PLoS One. 2010. PMID: 20976192 Free PMC article.
-
Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study.Appl Psychophysiol Biofeedback. 2016 Mar;41(1):61-9. doi: 10.1007/s10484-015-9312-y. Appl Psychophysiol Biofeedback. 2016. PMID: 26346569 Free PMC article.
-
Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions.Neurosci Lett. 2010 Mar 31;473(1):11-5. doi: 10.1016/j.neulet.2010.01.068. Epub 2010 Feb 2. Neurosci Lett. 2010. PMID: 20132869 Free PMC article.
-
HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis.Transl Psychiatry. 2016 May 3;6(5):e797. doi: 10.1038/tp.2016.68. Transl Psychiatry. 2016. PMID: 27138796 Free PMC article.
-
No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.Neuromolecular Med. 2009;11(2):123-7. doi: 10.1007/s12017-009-8068-z. Epub 2009 Jun 10. Neuromolecular Med. 2009. PMID: 19513863
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical